Recombinant Human CD47 protein (rFc Tag)(HPLC verified)

种属

Human

纯度

>90 %, SDS-PAGE
>90 %, SEC-HPLC

标签

rFc Tag

生物活性

未测试

Cat no : Eg1767

Print datasheet

Synonyms

CD47 molecule, IAP, Integrin associated protein, Integrin-associated protein, Leukocyte surface antigen CD47



产品信息

纯度 >90 %, SDS-PAGE
>90 %, SEC-HPLC
内毒素 <0.1 EU/μg protein, LAL method
生物活性
Not tested
来源 HEK293-derived Human CD47 protein Gln19-Pro139 (Accession# Q08722-1) with a rabbit IgG Fc tag at the C-terminus.
基因ID 961
蛋白编号 Q08722-1
预测分子量 40.0 kDa
SDS-PAGE 50-60 kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

CD47, also known as integrin-associated protein (IAP), is a member of the immunoglobulin superfamily containing a five-pass transmembrane attachment. CD47 is heavily glycosylated and widely expressed by hematopoietic and nonhematopoietic cells. CD47 interacts with several membrane integrins and also acts as a receptor for thrombospondin (THBS1). It is involved in a range of cellular processes, including apoptosis, proliferation, adhesion, and migration. CD47 also functions as a ligand for signal regulatory protein-α (SIRPα). Upon binding CD47, SIRPα initiates a signaling cascade that results in the inhibition of phagocytosis.

参考文献:

1. Brown, E. (2001)J Clin Invest. Jun 15;107(12):1499–1500. 2. Entsar Eladl. et al.(2001) J Hematol Oncol. 2020 Jul 16;13:96. 3. Eric Brown.(2001) J Clin Invest. 107(12):1499–1500. 4. Yoji Murata. et al(2018) Cancer Sci.109(8):2349–2357.